Last updated 6/1/2026

Mark CubanNet Worth Estimate

Estimated Range$5.5B - $6.5B$5,500,000,000 - $6,500,000,000

Mark Cuban's net worth is best estimated around $5.5 billion to $6.5 billion, with a base near Forbes' $6.0 billion figure. The clearest pieces are his remaining Mavericks stake and the cash generated by selling control of the team. The rest sits in a less visible mix of liquid investments and private-company holdings.

Image: Gage SkidmoreCreative Commons Attribution-Share Alike 3.0

Drivers

Wealth Breakdown

8 reviewed sources8 high-quality sources

Wealth composition$5,995,000,0004 sources

Liquid and private portfolio1 input · 4 sources · 48/100 confidenceIncluded$3,500,000,000

Sale proceeds1 input · 4 sources · 68/100 confidenceIncluded$1,550,000,000

Sports team equity1 input · 4 sources · 76/100 confidenceIncluded$945,000,000

Not Counted Directly

External estimateContext only · $6,000,000,000

Estimate

Current Assessment

The public record supports Cuban as a multibillionaire, but not a precise balance sheet. Forbes listed him at about $6.0 billion in May 2026. The Mavericks sale provides the strongest hard evidence: Cuban sold control in 2023, retained a 27% stake and received an estimated $2 billion pre-tax from the sale of a 58% interest. His earlier Broadcast.com exit and a long-running private investment portfolio explain the remaining wealth, but those holdings are not publicly itemized.

Key caveats

Private-company values are not disclosed.
The after-tax Mavericks sale proceeds are estimated.
Cost Plus Drugs is relevant but not independently valued here.
No material public liabilities were found, but personal debt is not comprehensively disclosed.

Evidence gaps

Current cap tables for Cuban's private holdings
Exact Mavericks sale tax treatment and retained stake terms
Current valuation for Cost Plus Drugs
Real estate and liability records

Confidence

Medium

72/100

The draft is generally defensible for public use as a medium-confidence estimate. Identity is strongly supported, the Mavericks sale and retained-stake inputs are backed by reputable sources, and the public copy clearly discloses the major caveats. The main limitation is that the largest component, the residual liquid/private portfolio, is inferred from Forbes' external net-worth estimate and qualitative portfolio evidence rather than itemized holdings. This prevents high confidence but does not make the estimate irresponsible because the uncertainty is disclosed and the range is broad.

Medium confidence is appropriate because the core public estimate is anchored to Forbes and transaction-backed Mavericks evidence, while the largest residual portfolio component and exact post-tax sale proceeds rely on meaningful assumptions. The artifacts explicitly disclose private-company opacity, missing balance-sheet data, estimated tax treatment, and the limits of Cost Plus Drugs valuation evidence.

Key Evidence Gaps

Direct personal balance sheet or audited asset schedule.
Current private-company cap tables and Cuban ownership percentages.
Exact tax basis, taxes paid, transaction costs, and retained proceeds from the Mavericks sale.
Current retained Mavericks stake terms, including any buy-down option or minority discount evidence.
Current valuation and ownership evidence for Cost Plus Drugs.

Public Caveats

Public confidence: Medium.
The estimate relies partly on Forbes as an external benchmark, not an audited personal balance sheet.
The residual liquid and private-company portfolio is inferred, not itemized from disclosed holdings.
The after-tax Mavericks sale proceeds are estimated; actual tax treatment and retained proceeds are not public.

Range Model

Scenario Spread

Conservative

$4.8B - $5.7B

Base

$5.5B - $6.5B

Aggressive

$6.0B - $7.2B

Uncertainty Drivers

Cuban's actual post-tax proceeds from the Mavericks sale are not disclosed.
Current Dallas Mavericks valuation and any contractual option reducing Cuban's stake may differ from the 2023 transaction valuation.
Private-company stakes, including Cost Plus Drugs and Shark Tank holdings, have undisclosed ownership percentages and valuations.
Liquid portfolio composition, charitable transfers, taxes, hedges and liabilities are not publicly itemized.
Forbes' billionaire estimate is reputable but remains an external model.

Evidence

Reviewed Signals

Signal	Value	Confidence
Sports and real-estate strategy context Cuban's sale rationale points to changing economics around NBA teams, arenas and destination development.	n/a	60/100
Cost Plus Drugs stake Cost Plus Drugs is a high-profile operating company associated with Cuban, but public sources did not disclose his equity percentage or valuation.	Undisclosed	55/100
Private company and Shark Tank portfolio Cuban holds or has held numerous private investments, including Shark Tank-related companies and broader Mark Cuban Companies portfolio holdings.	Material but undisclosed private portfolio	62/100
Broadcast.com liquidity origin Yahoo's 1999 Broadcast.com acquisition made Cuban a billionaire and seeded later liquid investments.	Historic multibillion-dollar company sale; personal current value not disclosed	80/100
Retained Mavericks stake Cuban's retained 27% minority stake in the Mavericks valued against AP's reported $3.5 billion transaction valuation.	$945,000,000	78/100
Mavericks control-sale proceeds Estimated pre-tax proceeds from Cuban's December 2023 Mavericks sale.	$1,550,000,000	72/100
Forbes net worth benchmark Forbes' current public estimate of Cuban's total net worth.	$6,000,000,000	84/100

Citations

Sources

Feedback

Correction

Public estimates are reviewed but uncertain. Submit a correction if a source or assumption should be updated.

Submit correction